Roger  Crystal net worth and biography

Roger Crystal Biography and Net Worth

Roger Crystal brings more than 15 years of experience as a healthcare business executive and clinician. He previously served as the Chief Business Officer for ImaginAb, a venture capital-backed biotechnology company, leading the company’s efforts in immuno-oncology and managing its pharmaceutical company partnerships and licensing deals. He began his business career with roles at Goldman Sachs, A.T. Kearney, and GE Healthcare. He holds a BMedSci in Physiology and an MD from the University of Birmingham, UK and an MBA from the London Business School. Prior to his business career, Dr. Crystal worked for several years as a surgeon, specializing in ear, nose, and throat, head and neck surgery at leading institutions including Imperial College Healthcare, London and was awarded Membership of The Royal College of Surgeons of England (MRCS). He was also an Honorary Research Fellow at University College London and has authored a number of peer-reviewed scientific articles.

He is the lead inventor of the NARCAN® Nasal Spray, holding several issued patents around this product, and led its development towards FDA approval. Dr. Crystal is frequently featured as an opioid crisis expert, including national TV appearances with prominent U.S. news media, and has testified at The White House, advising the President’s Opioid Committee. He serves on the Board of Directors of the Biotechnology Innovation Organization (BIO). He is also a member of the Young Presidents’ Organization, Santa Monica Bay Chapter.

What is Roger Crystal's net worth?

The estimated net worth of Roger Crystal is at least $0.00 as of January 27th, 2023. Dr. Crystal owns 75,339 shares of Opiant Pharmaceuticals stock worth more than $0 as of December 22nd. This net worth estimate does not reflect any other assets that Dr. Crystal may own. Learn More about Roger Crystal's net worth.

How do I contact Roger Crystal?

The corporate mailing address for Dr. Crystal and other Opiant Pharmaceuticals executives is 233 WILSHIRE BLVD. SUITE 280, SANTA MONICA CA, 90401. Opiant Pharmaceuticals can also be reached via phone at (310) 598-5410 and via email at [email protected]. Learn More on Roger Crystal's contact information.

Has Roger Crystal been buying or selling shares of Opiant Pharmaceuticals?

Roger Crystal has not been actively trading shares of Opiant Pharmaceuticals within the last three months. Most recently, Roger Crystal sold 1,358 shares of the business's stock in a transaction on Friday, January 27th. The shares were sold at an average price of $20.26, for a transaction totalling $27,513.08. Following the completion of the sale, the chief executive officer now directly owns 75,339 shares of the company's stock, valued at $1,526,368.14. Learn More on Roger Crystal's trading history.

Who are Opiant Pharmaceuticals' active insiders?

Opiant Pharmaceuticals' insider roster includes Craig Collard (Director), Roger Crystal (CEO), David O'Toole (CFO), Matthew Ruth (Insider), Michael Sinclair (Director), Phil Skolnick (Insider), and Thomas Thomas (Director). Learn More on Opiant Pharmaceuticals' active insiders.

Roger Crystal Insider Trading History at Opiant Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/27/2023Sell1,358$20.26$27,513.0875,339View SEC Filing Icon  
1/9/2023Sell1,183$20.20$23,896.6076,697View SEC Filing Icon  
1/5/2023Sell5,029$20.20$101,585.8077,880View SEC Filing Icon  
7/14/2022Sell2,246$11.11$24,953.0682,909View SEC Filing Icon  
1/27/2022Sell1,995$26.15$52,169.25View SEC Filing Icon  
1/10/2022Sell1,058$30.49$32,258.42View SEC Filing Icon  
4/8/2019Sell28,773$12.03$346,139.19View SEC Filing Icon  
4/4/2019Sell21,227$12.00$254,724.00View SEC Filing Icon  
1/8/2019Sell50,000$13.34$667,000.00View SEC Filing Icon  
10/9/2018Sell10,847$17.21$186,676.87View SEC Filing Icon  
10/4/2018Sell18,450$18.11$334,129.50View SEC Filing Icon  
1/17/2017Buy3,475$6.99$24,290.258,475View SEC Filing Icon  
See Full Table

Roger Crystal Buying and Selling Activity at Opiant Pharmaceuticals

This chart shows Roger Crystal's buying and selling at Opiant Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Opiant Pharmaceuticals Company Overview

Opiant Pharmaceuticals logo
Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $20.58
Low: $20.03
High: $21.10

2 Week Range

Now: N/A

Volume

562,700 shs

Average Volume

77,920 shs

Market Capitalization

$108.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84